Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2000
12/28/2000WO2000078343A2 Method for treating chronic hbv infection
12/28/2000WO2000078332A2 Fish serine proteinases and their pharmaceutical and cosmetic use
12/28/2000WO2000078330A2 Adenosine diphosphatase and activators thereof and their medical uses
12/28/2000WO2000078324A1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof
12/28/2000WO2000078322A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
12/28/2000WO2000078317A1 Integrin receptor antagonists
12/28/2000WO2000078315A1 Cyclohexenyl-ethyl-thiourea compounds and use
12/28/2000WO2000078310A1 Indole compounds
12/28/2000WO2000078309A1 Indole compounds
12/28/2000WO2000078308A1 Antibiotic compound
12/28/2000WO2000078275A2 Antibacterial compositions
12/28/2000WO2000078266A2 Interferon tau mutants and methods for making them
12/28/2000WO2000063348A3 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
12/28/2000WO2000061551A3 Pyrimidine-2-one derivatives as integrin receptor ligands
12/28/2000WO2000056353A3 A uro-genital condition treatment system
12/28/2000WO2000053767A3 Nucleic acid respiratory syncytial virus vaccines
12/28/2000WO2000053729A3 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine
12/28/2000WO2000050074A3 Neisserial vaccine compositions and methods
12/28/2000WO2000050051A3 Reovirus for the treatment of cellular proliferative disorders
12/28/2000WO2000045851A3 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
12/28/2000WO2000043495A3 33 human secreted proteins
12/28/2000WO2000043373A3 Kinase inhibitors
12/28/2000WO2000035465A3 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
12/28/2000WO2000034315A3 Purification of echinocandin cyclopeptide compounds
12/28/2000DE19929410A1 New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis
12/28/2000CA2382425A1 Interferon tau mutants and methods for making them
12/28/2000CA2377648A1 Prion protein peptides and uses thereof
12/28/2000CA2377357A1 Fish serine proteinases and their pharmaceutical and cosmetic use
12/28/2000CA2376077A1 Integrin receptor antagonists
12/28/2000CA2376007A1 Antibiotic compound
12/28/2000CA2375508A1 Methods and products for manipulating uncoupling protein expression
12/28/2000CA2375493A1 Human transport proteins
12/28/2000CA2375407A1 Rna metabolism proteins
12/28/2000CA2375358A1 Antibiotic agents
12/28/2000CA2375356A1 Substituted benzamide inhibitors of rhinovirus 3c protease
12/28/2000CA2375342A1 Phenetyl-thiourea compounds for treating hiv infections
12/28/2000CA2375261A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv
12/28/2000CA2375229A1 Method and compounds for inhibiting activity of serine elastases
12/28/2000CA2375211A1 Antiviral agents
12/28/2000CA2373375A1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
12/28/2000CA2368099A1 Adenosine diphosphatase and activators thereof and their medical uses
12/27/2000EP1063228A1 Cycloalkene derivatives, process for producing the same, and use
12/27/2000EP1062950A2 1,3 Oxathiolane nucleoside analogues
12/27/2000EP1062336A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
12/27/2000EP1062330A2 Ribozymes capable of inhibiting the expression of the ccr5 receptor
12/27/2000EP1062325A2 Purification of virus preparations
12/27/2000EP1062229A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/27/2000EP1062225A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS)
12/27/2000EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
12/27/2000EP1062214A1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels
12/27/2000EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
12/27/2000EP1062204A1 Modulators of protein tyrosine phosphatases (ptpases)
12/27/2000EP1062199A1 Modulators of protein tyrosine phosphatases (ptpases)
12/27/2000EP1061953A1 Analgesic combination comprising nmda receptor antagonists and narcotic analgesics
12/27/2000EP1061950A1 Live vaccine for human immunodeficiency virus
12/27/2000EP1061922A1 USE OF $i(N)-SUBSTITUTED-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL COMPOUNDS FOR TREATING HEPATITIS VIRUS INFECTIONS
12/27/2000EP1061903A1 Delivery system to modulate immune response
12/27/2000EP1061812A1 Food products having enhanced cocoa polyphenol content and processes for producing same
12/27/2000EP1061805A1 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2000EP1022278A4 Tetracyclical derivatives from pyrimidine
12/27/2000EP1021180A4 Mixed cyanoacrylate ester compositions
12/27/2000EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
12/27/2000EP0793472A4 Method of using lectins for agglutination and collection of menstrual flow
12/27/2000EP0791065B1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
12/27/2000EP0554319B1 Antimicrobial composition
12/27/2000CN1278266A 6,11-bridged erythromycin derivatives
12/27/2000CN1277873A Application of VMIP derivatives in medicine for treating AIDS and inflammation pathology
12/27/2000CN1277842A Chemical graft anti-gonococcus medicinal soluble cotton yarn, and it prepn. method
12/27/2000CN1059905C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
12/27/2000CN1059801C Medicine for treating cold
12/26/2000USRE37003 Unit dosage form of a 1,3-bis-triazolyl-2-propanol derivative of given formula; side effect reduction
12/26/2000US6166199 Contacting purine with amino, hydrazine, hydroxylamine, thiol, semicarbazide, thiosemicarbazide, hydrazone, hydrazide, imidazole, tetrazole, triazole, pyrrolidine, piperidine, piperazine, morpholine, aldehyde, ketone, alcohol; antisense
12/26/2000US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy
12/26/2000US6166185 Antibodies to human TIE-2 ligands
12/26/2000US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections
12/26/2000US6166062 Pharmaceutical compositions containing phospholipase inhibitor
12/26/2000US6166056 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
12/26/2000US6166048 Pharmaceutical compositions for inhibition of cytokine production and secretion
12/26/2000US6166018 For treating fungal infection wherein said fungal infection is central candidiasis
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/26/2000US6165999 Tetracycline derivatives
12/26/2000US6165997 Phospholipids having antimicrobial activity with or without the presence of antimicrobials
12/26/2000US6165996 Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis
12/26/2000US6165992 Histidine kinase
12/26/2000US6165989 An isolated polynucleotide comprising a first polynucleotide or the full complement of the entire length of the first polynucleotide, wherein the first polynucleotide encodes a polypeptide comprising specific amino acid sequence
12/26/2000US6165980 Distamycin derivatives, wherein the distamycin formyl group is substituted by a benzoyl group bearing alkylating group a bis-halo-ethylamino or a n-alkyl-n-haloethyl-amino group, while amidine group is substituted by various nitrogen groups
12/26/2000US6165794 Suppression of proteolytic activity by dysfunctional protease formation
12/26/2000US6165774 Culturing virus in cells, separating out virus, solubilizing hemagglutinin-neuramidase and fusion envelope glycoproteins from virus, and coisolating and copurifying using ion exchange chromatography and hydroxyapatite matrix
12/26/2000US6165766 Amino acid sequence of serine/threonine protein kinase; anticarcinogenic/antiarthritic/antiinflammatory agents; treatment of osteoporosis, adult respiratory disease syndrome, inflammatory bowel disease, eating disorders; diagnosis
12/26/2000US6165764 Polynucleotides encoding tRNA methyl transferases from Streptococcus pneumoniae
12/26/2000US6165763 Nucleotide and amino acid sequences of enzyme from streptococcus; for drug screening of bacteriostats and bactericides
12/26/2000US6165762 Amino acid sequence of enzyme; drug screening of bactericides and bacteriostats; vaccines; diagnosis of infections
12/26/2000US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators
12/26/2000US6165732 Drug screening by using lipid bilayer that has potassium- or chloride-selective channel formed from polpeptide of bcl-2 family, contacting compound with bilayer, and determining ion-selectivity of channel; indicates agonist or antagonist
12/26/2000US6165730 Amino acid sequences of epitopes; for immunoassay diagnosis and immunogens for vaccines
12/26/2000US6165503 Preparing gelled beads of a polyanionic polysaccharide which are cross-linked with a polyvalent cation, forming capsules having polycationic-polyanion membrane of polycationic polysaccharide on gelled beads, culturing the product capsule
12/26/2000US6165502 Protein-lipid vesicles and autogenous vaccine comprising the same
12/26/2000US6165493 "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
12/26/2000US6165477 Mature recombinantly produced protein from eucaryotic cells which is protective against dengue infection, which raises antibodies useful in passive immunization, and which is useful in diagnosis of infection by the virus.
12/26/2000US6165472 Folyl-polyglutamate synthetase (fpgs) of s. pnuemoniae is necessary for a fully functional folate synthesis pathway. having a present benefit of being useful to screen compounds for antibiotic activity.
1 ... 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 ... 1798